MPL exon 10 mutations in Irish patients with a suspected myeloproliferative neoplasm
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
MPL exon 10 mutations in Irish patients with a suspected myeloproliferative neoplasm ; volume:20 ; day:01 ; month:02 ; year:2021
EXCLI journal ; 20 (01.02.2021)
- Creator
-
Lee Tokar, Lisa
Kearney, Laura
Langabeer, Stephen E.
- DOI
-
10.17179/excli2021-3454
- URN
-
urn:nbn:de:101:1-2021051813361747915230
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee Tokar, Lisa
- Kearney, Laura
- Langabeer, Stephen E.
Other Objects (12)
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm
Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm
Cerebral salt wasting in a patient with myeloproliferative neoplasm
The Myeloproliferative Neoplasm Landscape: A Patient’s Eye View
Megakaryocytic morphology in Janus kinase 2 V617F positive myeloproliferative neoplasm
Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm
A Case of Acquired von Willebrand Disease Secondary to Myeloproliferative Neoplasm
Order-of-Mutation Effects on Cancer Progression: Models for Myeloproliferative Neoplasm
p27KIP1 and PTEN cooperate in myeloproliferative neoplasm tumor suppression in mice
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm
Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm
Cerebral salt wasting in a patient with myeloproliferative neoplasm
The Myeloproliferative Neoplasm Landscape: A Patient’s Eye View
Megakaryocytic morphology in Janus kinase 2 V617F positive myeloproliferative neoplasm
Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm
A Case of Acquired von Willebrand Disease Secondary to Myeloproliferative Neoplasm
Order-of-Mutation Effects on Cancer Progression: Models for Myeloproliferative Neoplasm
p27KIP1 and PTEN cooperate in myeloproliferative neoplasm tumor suppression in mice
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm
Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm
Cerebral salt wasting in a patient with myeloproliferative neoplasm
The Myeloproliferative Neoplasm Landscape: A Patient’s Eye View
Megakaryocytic morphology in Janus kinase 2 V617F positive myeloproliferative neoplasm
Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm
A Case of Acquired von Willebrand Disease Secondary to Myeloproliferative Neoplasm
Order-of-Mutation Effects on Cancer Progression: Models for Myeloproliferative Neoplasm
p27KIP1 and PTEN cooperate in myeloproliferative neoplasm tumor suppression in mice